Ferric carboxymaltose for the treatment of iron‐deficient heart failure patients: a systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Ferric carboxymaltose for the treatment of iron‐deficient heart failure patients: a systematic review and meta‐analysis

Published:2020-12 Issue:6 Volume:7 Page:3392-3400
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Khan Muhammad Shahzeb¹,Usman Muhammad Shariq²,Haehling Stephan³⁴,Doehner Wolfram⁵⁶,Stewart Coats Andrew J.⁷⁸

Affiliation:

1. Department of Medicine University of Mississippi Medical Centre Jackson MS USA

2. Department of Medicine DOW University of Health Sciences Karachi Pakistan

3. Department of Cardiology and Pneumology University of Göttingen Medical Center Göttingen Germany

4. German Center for Cardiovascular Research (DZHK), partner site Göttingen Göttingen Germany

5. BCRT—Berlin Institute of Health Center for Regenerative Therapies, Charite Universitätsmedizin Berlin Berlin Germany

6. Department of Cardiology (Virchow Klinikum) Charité‐ Universitätsmedizin Berlin, German Centre for Cardiovascular Research (DZHK), Partner Site Berlin Berlin Germany

7. Monash University Australia

8. University of Warwick Coventry UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13146

Reference27 articles.

1. Anemia and Iron Deficiency in Heart Failure

2. Iron deficiency in chronic heart failure: case-based practical guidance

3. Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure?

4. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

5. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The long-term impact of increased red blood cell distribution width detected during hospitalization for heart failure;Biomarkers in Medicine;2024-09-10

2. Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis;Future Science OA;2024-07-09

3. Safety and Efficacy of Ferric Carboxymaltose in Heart Failure With Preserved Ejection Fraction and Iron Deficiency;Current Problems in Cardiology;2024-01

4. Prevention of Heart Failure;Preventive Cardiovascular Nursing;2024

5. Novel Issues in the Treatment of Heart Failure, Based on the European Society of Cardiology (ESC) 2023 Congress;International Journal of Cardiovascular Practice;2023-12-12